Evidence map›Paper›PMID 36668866›Full record

ArticleToxins2023

Discovery of the Nicotinic Receptor Toxin Anabaseine in a

William R Kem, James R Rocca, Jodie V Johnson, Juan Junoy

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

William R KemDepartment of Pharmacology and Therapeutics, University of Florida College of Medicine, 1200 Newell Drive, Gainesville, FL 32610, USA.ORCID 0000-0001-8492-3969
James R RoccaAMRIS, McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA.
Jodie V JohnsonDepartment of Chemistry, University of Florida, Gainesville, FL 32611, USA.
Juan JunoyDepartamento de Ciencias de la Vida, Universidad de Alcalá, 28805 Alcalá de Henares, Spain.ORCID 0000-0002-6125-558X
University of Florida · USUniversidad de Alcalá · ES

Funding

NMR console upgrade for structural biology and metabolomicsS10OD028753 · OD · UNIVERSITY OF FLORIDA · PI LONG, JOANNA R · 2020 to 2020
$600k
NIH HHS S10 OD028753
6 · The paper itself

Abstract

Nemerteans (also called Nemertines) are a phylum of predominantly marine worms that use toxins to capture prey and to defend themselves against predators. Hoplonemerteans have a proboscis armed with one or more stylets used in prey capture and are taxonomically divided into Order Monostilifera, whose members possess a single large proboscis stylet, and Order Polystilifera, whose members have multiple small stylets. Many monostiliferans contain alkaloidal toxins, including anabaseine, that stimulate and then desensitize nicotinic acetylcholine receptors that are present in all animals. These compounds also interact with pyridyl chemoreceptors in crustaceans, reducing predation and larval settlement. Anabaseine has been a lead compound in the design of alpha7 nicotinic acetylcholine receptor agonists like GTS-21 (also called DMXBA) to treat disorders of cognition such as Alzheimer's disease and schizophrenia. These drug candidates also display anti-inflammatory activities of potential medical importance. Most polystiliferans live deep in open oceans and are relatively inaccessible. We fortunately obtained two live specimens of a large benthic polystiliferan,

Indexed as

Receptors, NicotinicToxins, BiologicalAnabasineAnimalsBenzaldehydesBenzylidene CompoundsNicotinic AgonistsPyridines3-(2,4-dimethoxybenzylidene)anabaseineanabaseineAnabasineBenzaldehydesBenzylidene CompoundsNicotinic Agonistsp-dimethylaminobenzaldehydePyridinesReceptors, NicotinicToxins, Biologicalanabaseineanabasineehrlich reagentnemerteannemertinenicotinic acetylcholine receptortoxinvenom

Identifiers

PMID36668866
PMCPMC9867080
OpenAlexW4313570171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.